Clinical Trials Browser

Phase 2 × Lung Adenocarcinoma Metastatic × Crizotinib × Clear all

NCT02946359 2016-11-02

A+C in Metastatic Lung Adenocarcinoma Cancer

Phase 2 Unknown

Lung Adenocarcinoma Metastatic